[Management of chemotherapy side effects and their long-term sequelae].
Zraik IM, Heß-Busch Y.
Urologe A. 2021 Jul;60(7):862-871. doi: 10.1007/s00120-021-01569-7. Epub 2021 Jun 29.
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
Lyman GH, Abella E, Pettengell R.
Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12.
Enteral tube administration of oral chemotherapy drugs.
Spencer SH, Menard SM, Labedz MZ, Krueger CD, Sarna KV.
J Oncol Pharm Pract. 2020 Apr;26(3):703-717. doi: 10.1177/1078155219893449. Epub 2020 Jan 19.
Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring.
Knezevic CE, Clarke W.
Ther Drug Monit. 2020 Feb;42(1):6-19. doi: 10.1097/FTD.0000000000000701.
[Chemotherapy].
Fujita S, Kotake K.
Nihon Rinsho. 2014 Jan;72(1):102-7.
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
Davern M, Lysaght J.
Cancer Lett. 2020 Dec 28;495:89-99. doi: 10.1016/j.canlet.2020.09.014. Epub 2020 Sep 17.
Danger signals: Chemotherapy enhancers?
Rivera Vargas T, Apetoh L.
Immunol Rev. 2017 Nov;280(1):175-193. doi: 10.1111/imr.12581.
Chemotherapy for lung cancers: here to stay.
Kris MG, Hellmann MD, Chaft JE.
Am Soc Clin Oncol Educ Book. 2014:e375-80. doi: 10.14694/EdBook_AM.2014.34.e375.
Oral chemotherapy for the treatment of hepatocellular carcinoma.
Yamamoto S, Kondo S.
Expert Opin Pharmacother. 2018 Jun;19(9):993-1001. doi: 10.1080/14656566.2018.1479398. Epub 2018 Jun 18.
Chemotherapy is getting 'smarter'.
Mehrling T.
Future Oncol. 2015;11(4):549-52. doi: 10.2217/fon.14.248.
